ShiftPixy PIXY 深 沪
已收盘 10-25 16:00:00 美东时间
6.53
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 6.53
- 总市值 326.50万
- 52周最高 228.45
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 5.43
- 委 比 0.00%
- 总股本 50.00万
- 历史最高 16761600.00
- 量 比 0
- 振 幅 0.00%
- 历史最低 8.55
- 每 手 1
- 风险率 35.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ShiftPixy Faces Bankruptcy and Leadership Changes
ShiftPixy ( ($PIXY) ) has issued an update. ShiftPixy, Inc. has filed for Chapt...
2024-10-30 05:28
快讯 | shiftpixy在美国德国密西西比州联邦破产法院自愿申请根据美国法典第11章第11章寻求救济
ShiftPixy: Filed Voluntary Petition in U.S. Bankruptcy Court for Southern Distr...
2024-10-30 05:04
快讯 | ShiftPixy公司 - Whitney White、Christopher Sebes和Martin Scott辞去公司董事职务
ShiftPixy Inc - Whitney White, Christopher Sebes, and Martin Scott Resigned as ...
2024-10-30 05:04
Why ShiftPixy (PIXY) Stock Is Rising
ShiftPixy shares are trading higher by 11.7% during Wednesday's session. The company announced it signed a LOI to acquire TurboScale.
2024-10-23 23:28
Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
Shares of Stride, Inc. (NYSE:LRN) rose sharply in today's pre-market trading af...
2024-10-23 18:36
ShiftPixy jumps 25% on TurboScale acquisition for $150M
ShiftPixy (NASDAQ:PIXY) stock jumped 25% on Tuesday during after hour of trading as it announced plans to acquire TurboScale, an AI technology company, for a total of $150M. The acquisition is structu...
2024-10-23 13:21
Shift Pixy (NASDAQ:PIXY) Stock Soars 80% on TurboScale Acquisition
After a difficult month of mostly trending downward, ShiftPixy ($PIXY) is soari...
2024-10-18 01:34
Why Is GameSquare Stock Gaining Today?
GameSquare Holdings shares are up after announcing strong preliminary Q3 results and raising its 2024 revenue guidance to $105-$110 million.
2024-10-18 00:04
Iridium's Q3 Revenue Soars 8%, FY24 Outlook Brightens As Subscriber Base Expands
Iridium Communications exceeded Q3 revenue expectations and revised its FY24 OEBITDA guidance, with shares trading higher.
2024-10-17 22:30
After Series Of Trial Setbacks, Sage Therapeutics To Lay Off One-Third Workforce
Sage Therapeutics announces reorganization, including layoffs and pipeline changes, to support the launch of Zurzuvae. Focus shifts to Huntington's Disease trial after setbacks in essential tremor and Alzheimer's treatments.
2024-10-17 22:11
